Improved antibacterial activity of HAP garlanded PLGA ultrafine fibers incorporated with CuO: synthesis and characterization
Source abstract
Abstract
Well-organized nanocrystalline hydroxyapatite nanoparticles garlanded poly(dl-lactide-co-glycolide) (PLGA) ultrafine fibers with efficient antibacterial properties are of great interest in the development of new products. In the present study, hydroxyapatite doped PLGA ultrafine fibers incorporated with copper oxide nanocrystals were fabricated via two step methodology. Primarily; copper oxide nanocrystals were synthesized using wet chemical method. Then the as-synthesized nanocrystals were used for the preparation of composite fibers using electrospinning technique. The properties of pure and composite ultrafine fibers were characterized using X-ray diffraction, scanning electron microscopy, energy dispersive X-ray analysis, and electron probe mapping analysis. The in vitro antimicrobial activity of synthesized pure and hydroxyapatite doped PLGA ultrafine fibers was investigated against model organism Escherichia coli (gram negative) using optical density method and morphological damage was observed by TEM. Ultrafine fibers with average diameter ranges from 1.0 to 1.2 μm were obtained. Uniform distribution of hydroxyapatite was observed. Admirable antimicrobial activity against E. coli was achieved which could be attributed by the synergy between hydroxyapatite and copper oxide. In contrast to pristine PLGA, lower concentrations of hydroxyapatite–copper oxide doped PLGA nanocomposite were needed to strongly inhibit the growth of E. coli. Our results report successful preparation of hydroxyapatite–copper oxide based novel nanocomposite. The developed hybrid nanocomposite possess exceptionally good antibacterial activity against E. coli due to the synergistic effect of hydroxyapatite and copper oxide. The antimicrobial nanocomposite can be utilized for a range of bio-functional purposes such as a good candidate for water purification, antibiofouling, wound dressings and bone tissue engineering etc.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (25)
Show source-provided references
1. Moore MN (2006) Environ Int 32:967–97610.1016/j.envint.2006.06.014 ↗
2. Xin R, Leng Y, Chen J, Zhang Q (2005) Biomaterials 26:6477–648610.1016/j.biomaterials.2005.04.028 ↗
3. Ramila A, Vallet-Regi M (2001) Biomaterials 22:2301–230610.1016/S0142-9612(00)00419-1 ↗
4. Ragel CV, Vallet-Regi M, Rodriguez-Lorenzo LM (2002) Biomaterials 23:1865–187210.1016/S0142-9612(01)00313-1 ↗
5. Fujibayashi S, Neo M, Kim HM, Kokubo T, Nakamura T (2003) Biomaterials 24:1349–135610.1016/S0142-9612(02)00511-2 ↗
6. Siriphannon P, Kameshima Y, Yasumori A, Okada K, Hayashi S (2002) J Biomed Mater Res 60:175–18510.1002/jbm.10056 ↗
7. Wojciech S, Masahiro Y (1998) J Mater Res 13:94–11710.1557/JMR.1998.0015 ↗
8. Wei Y, Chen S, Kowalczyk B, Huda S, Gray TP, Grzybowski BA (2010) J Phys Chem C 114:15612–1561610.1021/jp1055683 ↗
9. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramírez JT, Yacaman MJ (2005) Nanotechnology 16:2346–235310.1088/0957-4484/16/10/059 ↗
10. Yoon K, Byeon JH, Park J, Hwang J (2007) Sci Total Environ 373:572–57510.1016/j.scitotenv.2006.11.007 ↗
11. Hassan MS, Amna T, Yang OB, El-Newehy MH, Al-Deyab SS, Khil MS (2012) Colloids Surf B Biointerfaces 97:201–20610.1016/j.colsurfb.2012.04.032 ↗
12. Cioffi N, Torsi L, Ditaranto N, Tantillo G, Ghibelli L, Sabbatini L, Bleve-Zacheo T, D’Alessio M, Zambonin PG, Traversa E (2005) Chem Mater 17:5255–526210.1021/cm0505244 ↗
13. Nel A, Xia T, Mädler L, Li N (2006) Science 311:622–62710.1126/science.1114397 ↗
14. Sen CK, Khanna S, Venojarvi M, Trikha P, Ellison EC, Hunt TK, Roy S (2002) Am J Physiol Heart Circ Physiol 282(5):H1821–H182710.1152/ajpheart.01015.2001 ↗
15. Gorter RW, Butorac M, Cobian EP (2004) Am J Ther 11:453–45810.1097/01.mjt.0000127148.83065.e5 ↗
16. Ciobanu CS, Massuyeau F, Constantin LV, Predoi D (2011) Nanoscale Res Lett 6:613–67010.1186/1556-276X-6-613 ↗
17. Ciobanu CS, Iconaru SL, Coustumer PL, Constantin LV, Predoi D (2012) Nanoscale Res Lett 7:324–34210.1186/1556-276X-7-324 ↗
18. Feng QL, Kim TN, Wu J, Park ES, Kim JO, Lim DY, Cui FZ (1998) Thin Solid Films 335:214–21910.1016/S0040-6090(98)00956-0 ↗
19. Drelich J, Li B, Bowen P, Hwang JY, Mill O, Hoffman D (2011) Appl Surf Sci 257:9435–944310.1016/j.apsusc.2011.06.027 ↗
20. Hassan MS, Amna T, Mishra A, Yun SI, Kim HC, Kim HY, Khil MS (2012) J Biomed Nanotechnol 8:394–40410.1166/jbn.2012.1393 ↗
21. Thurman RB, Gerba CP (1989) CRC Crit Rev Environ Control 18:295–31510.1080/10643388909388351 ↗
22. Sterritt RM, Lester JN (1980) Sci Total Environ 14:5–1710.1016/0048-9697(80)90122-9 ↗
23. Manzl C, Enrich J, Ebner H, Dallinger R, Krumschnabel G (2004) Toxicology 196:57–6410.1016/j.tox.2003.11.001 ↗
24. Domek MJ, Lechevallier MW, Cameron SC, McFeters GA (1984) Appl Environ Microbiol 48:289–29310.1128/AEM.48.2.289-293.1984 ↗
25. Domek MJ, Robbins JE, Anderson ME, McFeters GA (1987) Can J Microbiol 33:57–6210.1139/m87-010 ↗